These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12012263)

  • 1. [Disturbances of body-experience in acute anxiety and depressive disorders - neuroticism or somatization?].
    Röhricht F; Beyer W; Priebe S
    Psychother Psychosom Med Psychol; 2002 May; 52(5):205-13. PubMed ID: 12012263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Follow-up study of quality of life and treatment of eating disorder: dynamics of the depressive and anxiety symptoms].
    Banaś A; Januszkiewicz-Grabias A; Radziwiłłowicz P; Smoczyński S
    Psychiatr Pol; 2002; 36(6 Suppl):323-9. PubMed ID: 12647456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders.
    Koh KB; Kim DK; Kim SY; Park JK; Han M
    Psychiatry Res; 2008 Sep; 160(3):372-9. PubMed ID: 18718675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Somatic symptoms of depression].
    Güleç H; Sayar K; Ozkorumak E
    Turk Psikiyatri Derg; 2005; 16(2):90-6. PubMed ID: 15981146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Affective perception of the body in neurotics. Its relation to anxiety, depression, and various types of defense].
    Buxant P
    Acta Psychiatr Belg; 1976 May; 76(3):415-37. PubMed ID: 1020680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subsyndromal depressive symptoms in patients with bipolar and unipolar disorder during clinical remission.
    Vieta E; Sánchez-Moreno J; Lahuerta J; Zaragoza S;
    J Affect Disord; 2008 Apr; 107(1-3):169-74. PubMed ID: 17870184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Body image of patients with acute paranoid schizophrenia. A follow-up study].
    Röhricht F; Priebe S
    Nervenarzt; 1996 Jul; 67(7):602-7. PubMed ID: 8927200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
    Graystone HJ; Garner MJ; Baldwin DS
    J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression and somatic symptoms scale: a new scale with both depression and somatic symptoms emphasized.
    Hung CI; Weng LJ; Su YJ; Liu CY
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):700-8. PubMed ID: 17109704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain-related anxiety and anxiety sensitivity across anxiety and depressive disorders.
    Carleton RN; Abrams MP; Asmundson GJ; Antony MM; McCabe RE
    J Anxiety Disord; 2009 Aug; 23(6):791-8. PubMed ID: 19362446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The association between disability and residual symptoms in depressive patients: a 3-month follow-up].
    Ozyüksel B; Uluğ B
    Turk Psikiyatri Derg; 2007; 18(4):323-32. PubMed ID: 18066723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric symptoms in clients presenting for commercial weight reduction treatment.
    Goldstein LT; Goldsmith SJ; Anger K; Leon AC
    Int J Eat Disord; 1996 Sep; 20(2):191-7. PubMed ID: 8863072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of anxiety and depression in childhood migraine.
    Braccili T; Montebello D; Verdecchia P; Crenca R; Redondi A; Turri E; Turaccio R; Lendvai D
    Eur Rev Med Pharmacol Sci; 1999; 3(1):37-9. PubMed ID: 10710829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body image and self-esteem in somatizing patients.
    Sertoz OO; Doganavsargil O; Elbi H
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):508-15. PubMed ID: 19531108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.